IL17A and Miyoshi myopathy: Moreover, with potential clinical implications, the expression of IL-17 receptor (IL-17R) is higher on MM cells than normal plasma cells, and a monoclonal antibody directed against IL-17R inhibited MM cell proliferation in the presence of IL-17 [8].